USD 24.43
(-2.59%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 13.22 Billion | 11.08 Billion | 10.79 Billion | 6.48 Billion | 5.56 Billion | 4.57 Billion |
Net Income | 6.95 Billion | 5.69 Billion | 4.81 Billion | 3.53 Billion | 4.81 Billion | 4.47 Billion |
Depreciation & Amortization | 543 Million | 510 Million | 493 Million | 523 Million | 499.56 Million | 395.95 Million |
Deferred income taxes | -1.14 Billion | -4.76 Billion | -5.33 Billion | -1.12 Billion | -74.35 Million | 600.32 Million |
Stock-based compensation | 61 Million | 80 Million | 73 Million | 76 Million | 69 Million | 65.8 Million |
Change in working capital | 5.81 Billion | 4.68 Billion | 5.26 Billion | 1.14 Billion | 5.35 Million | -666.12 Million |
Other non-cash items | 1 Billion | 4.88 Billion | 5.49 Billion | 2.32 Billion | 256.95 Million | 1.16 Billion |
Investing Cash Flow | -28.7 Billion | -13.21 Billion | -29.7 Billion | -9.32 Billion | -7.46 Billion | -12.1 Billion |
Investments in PPE | -47.14 Billion | -37.71 Billion | -42.07 Billion | -38.36 Billion | -368.27 Million | -296.5 Million |
Acquisitions | 89 Million | 128 Million | 152 Million | 118 Million | 143.99 Million | 59.74 Million |
Investment purchases | -32.65 Billion | -14.53 Billion | -20.04 Billion | -20.03 Billion | -16.11 Billion | -14.4 Billion |
Sales/Maturities of investments | 18.03 Billion | 15.51 Billion | 14.25 Billion | 12.13 Billion | 13.31 Billion | 12.53 Billion |
Other Investing Activities | 32.97 Billion | 23.39 Billion | 18.01 Billion | 36.81 Billion | -4.44 Billion | -1.96 Billion |
Financing Cash Flow | 14.94 Billion | 9.95 Billion | 20.02 Billion | 5.91 Billion | 6.46 Billion | 7.31 Billion |
Debt repayment | -5.14 Billion | -5.24 Billion | -5.58 Billion | -4.56 Billion | -134.39 Million | -859.93 Million |
Dividends payments | -3.73 Billion | -2.62 Billion | -1.54 Billion | -1.46 Billion | -601.79 Million | -1.13 Billion |
Common Stock Repurchased | -205 Million | -250 Million | -406 Million | -63 Million | -191.34 Million | -2.71 Billion |
Common Stock Issuance | 112 Million | 150 Million | 140 Million | 16 Million | 87.52 Million | 106.57 Million |
Other Financing Activities | -494 Million | 17.91 Billion | 27.41 Billion | 11.98 Billion | 7.3 Billion | 997.78 Million |
Accounts receivables | 3.28 Billion | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 5.81 Billion | 4.68 Billion | 5.26 Billion | 1.14 Billion | 5.35 Million | -9.85 Billion |
Cash at beginning of period | 29.98 Billion | 22.71 Billion | 22.07 Billion | 18.06 Billion | 13.38 Billion | 13.83 Billion |
Cash at end of period | 28.87 Billion | 29.98 Billion | 22.71 Billion | 22.07 Billion | 18.06 Billion | 13.38 Billion |
Capital Expenditure | -47.14 Billion | -37.71 Billion | -42.07 Billion | -38.36 Billion | -368.27 Million | -296.5 Million |
Effect of forex changes on cash | -142 Million | -773 Million | 282 Million | 253 Million | -114 Million | -236.36 Million |
Net cash flow / Change in cash | -1.11 Billion | 7.27 Billion | 632 Million | 4.01 Billion | 4.67 Billion | -449.07 Million |
Free Cash Flow | -33.92 Billion | -26.63 Billion | -31.28 Billion | -31.88 Billion | 5.19 Billion | 4.28 Billion |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 3.92 Billion | 3.43 Billion | 6.95 Billion | 3.58 Billion | 5.69 Billion | 2.93 Billion |
Depreciation & Amortization | 256 Million | 280 Million | 543 Million | 263 Million | 510 Million | 272 Million |
Deferred income taxes | - | -585 Million | -1.14 Billion | -562 Million | -4.76 Billion | -6.59 Billion |
Stock-based compensation | 30 Million | 25 Million | 61 Million | 36 Million | 80 Million | 37 Million |
Change in working capital | -5.33 Billion | -2.45 Billion | 5.81 Billion | -11.28 Billion | 4.68 Billion | -1.11 Billion |
Other non-cash items | -4.26 Billion | 6.24 Billion | 1 Billion | -5.54 Billion | 4.88 Billion | 993 Million |
Investing Cash Flow | -2.1 Billion | -5.57 Billion | -28.7 Billion | -4.88 Billion | -13.21 Billion | -3.12 Billion |
Investments in PPE | -203 Million | -340 Million | -47.14 Billion | -197 Million | -37.71 Billion | -290 Million |
Acquisitions | -31 Million | 68 Million | 89 Million | 21 Million | 128 Million | 61 Million |
Investment purchases | -19.88 Billion | -22.51 Billion | -32.65 Billion | -10.14 Billion | -14.53 Billion | -8.52 Billion |
Sales/Maturities of investments | 20.99 Billion | 15.79 Billion | 18.03 Billion | 2.24 Billion | 15.51 Billion | 7.5 Billion |
Other Investing Activities | -1.87 Billion | -5.23 Billion | 32.97 Billion | -4.68 Billion | 23.39 Billion | -2.83 Billion |
Financing Cash Flow | 10.72 Billion | -2.64 Billion | 14.94 Billion | 17.54 Billion | 9.95 Billion | 2.31 Billion |
Debt repayment | -4.76 Billion | -7.91 Billion | -5.14 Billion | -6.56 Billion | -5.24 Billion | -2.46 Billion |
Dividends payments | -1.91 Billion | -1.9 Billion | -3.73 Billion | -1.83 Billion | -2.62 Billion | -1.33 Billion |
Common Stock Repurchased | -148 Million | -1.09 Billion | -205 Million | -115 Million | -250 Million | -97 Million |
Common Stock Issuance | 57 Million | 76 Million | 112 Million | 36 Million | 150 Million | 83 Million |
Other Financing Activities | 8.02 Billion | 343 Million | -494 Million | 26.05 Billion | 17.91 Billion | 3.74 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -5.33 Billion | -2.45 Billion | 5.81 Billion | -11.28 Billion | 4.68 Billion | -1.11 Billion |
Cash at beginning of period | 28.87 Billion | 30.03 Billion | 29.98 Billion | 29.45 Billion | 22.71 Billion | 28.21 Billion |
Cash at end of period | 32.25 Billion | -783 Million | 28.87 Billion | 30.03 Billion | 29.98 Billion | 29.98 Billion |
Capital Expenditure | -203 Million | -340 Million | -47.14 Billion | -197 Million | -37.71 Billion | -290 Million |
Effect of forex changes on cash | 151 Million | -474 Million | -142 Million | 332 Million | -773 Million | -538 Million |
Net cash flow / Change in cash | 3.37 Billion | -30.81 Billion | -1.11 Billion | 580 Million | 7.27 Billion | 1.77 Billion |
Free Cash Flow | -5.58 Billion | 7.18 Billion | -33.92 Billion | -13.13 Billion | -26.63 Billion | 2.83 Billion |
ALAGP
002595
SANU
JAL
MEDICAMEQ
OGN